Tianjin Pharma DRT (SH600329)
Group Profile
Heritage of Ingenuity
Group News
Health Self-Check
Health Guide
中文
中文
English
search
Group Profile
Group Introduction
History
Corporate Culture
Group Industry
ESG
Brand Display
Heritage of Ingenuity
Heritage of Ingenuity
Product Center
Product Family
Products and Services
Group News
Group News
Health Guide
Health Information
Media Coverage
Investor Relations
Stock Information
Company Announcements
Investor Contact
集团党建
党建新闻
执纪监督
Join Us
Talent Concept
Recruitment Information
Contact Us
Contact Us
Tianjin Pharma DRT (SH600329)
35.17
+0.35 +1.01%
中文
English
Home Page
Group Profile
Group Introduction
History
Corporate Culture
Group Industry
ESG
Brand Display
Heritage of Ingenuity
Product Center
Product Family
Products and Services
Group News
Health Guide
Health Information
Media Coverage
Investor Relations
Stock Information
Company Announcements
Investor Contact
集团党建
党建新闻
执纪监督
Join Us
Talent Concept
Recruitment Information
Contact Us
Online Mall
Latest news
Group News
Home Page
Group News
2026 / 05 / 12
达仁堂现代中药贴剂成果引业内关注
作为制药行业年度重要盛会,日前,CPI 2026京津冀制药工业大会暨制药全产业链资源对接大会在京举行。
Learn More
2026 / 01 / 13
津药达仁堂荣膺“2025年度十大医药公益企业”
2026 / 01 / 12
一路向C!达仁堂舒脑欣滴丸开启O2O新篇章
2026 / 01 / 10
新华社参考消息:东方智慧与国际接轨 中医药出海破壁前行
2026 / 01 / 09
腾讯健康与津药达仁堂达成战略合作 「数字运河」再扩容!
2026 / 01 / 08
慢阻肺中西医结合诊疗再升级 参苓白术获指南推荐
2026 / 01 / 04
达仁堂荣膺“第三终端优秀医药企业”
11
12
13
14
15
16
17
18
19
20
We are the Leader of Chinese Medicine and Striving to Become a Leader in Innovative Medicine in China
Home Page
>
Group News